These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29423049)

  • 1. Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.
    Fukushiro-Lopes DF; Hegel AD; Rao V; Wyatt D; Baker A; Breuer EK; Osipo C; Zartman JJ; Burnette M; Kaja S; Kouzoukas D; Burris S; Jones WK; Gentile S
    Oncotarget; 2018 Jan; 9(3):3321-3337. PubMed ID: 29423049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma.
    Perez-Neut M; Haar L; Rao V; Santha S; Lansu K; Rana B; Jones WK; Gentile S
    Oncotarget; 2016 Apr; 7(16):21991-2004. PubMed ID: 26942884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling.
    Breuer EK; Fukushiro-Lopes D; Dalheim A; Burnette M; Zartman J; Kaja S; Wells C; Campo L; Curtis KJ; Romero-Moreno R; Littlepage LE; Niebur GL; Hoskins K; Nishimura MI; Gentile S
    Cell Death Dis; 2019 Feb; 10(3):180. PubMed ID: 30792401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hERG1/Kv11.1 activation stimulates transcription of p21waf/cip in breast cancer cells via a calcineurin-dependent mechanism.
    Perez-Neut M; Rao VR; Gentile S
    Oncotarget; 2016 Sep; 7(37):58893-58902. PubMed ID: 25945833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Activation of the Kv11.1 Channel Reprograms EMT in Colon Cancer by Inhibiting TGFβ Signaling via Activation of Calcineurin.
    Eskandari N; Senyuk V; Moore J; Kalik Z; Luan Q; Papautsky I; Moshiri A; Bocchetta M; Salami SA; Oryan S; Gentile S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel perspectives in cancer therapy: Targeting ion channels.
    Arcangeli A; Becchetti A
    Drug Resist Updat; 2015; 21-22():11-9. PubMed ID: 26183291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs.
    Senyuk V; Eskandari N; Jiang Y; Garcia-Varela R; Sundstrom R; Leanza L; Peruzzo R; Burkard M; Minshall RD; Gentile S
    Redox Biol; 2021 Sep; 45():102030. PubMed ID: 34147842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Modulation of Neuronal K
    Dierich M; Evers S; Wilke BU; Leitner MG
    Front Mol Neurosci; 2018; 11():11. PubMed ID: 29440988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.
    Perry MD; Ng CA; Phan K; David E; Steer K; Hunter MJ; Mann SA; Imtiaz M; Hill AP; Ke Y; Vandenberg JI
    J Physiol; 2016 Jul; 594(14):4031-49. PubMed ID: 26958806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Modulation of Kv11.1 (hERG) Channels Protects Against Drug-Induced Ventricular Arrhythmias.
    Yu Z; Liu J; van Veldhoven JP; IJzerman AP; Schalij MJ; Pijnappels DA; Heitman LH; de Vries AA
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003439. PubMed ID: 27071825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of drug interaction with the Kv11.1 potassium channel.
    Hill AP; Perrin MJ; Heide J; Campbell TJ; Mann SA; Vandenberg JI
    Mol Pharmacol; 2014 May; 85(5):769-76. PubMed ID: 24586056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic electroconvulsive stimulation but not chronic restraint stress modulates mRNA expression of voltage-dependent potassium channels Kv7.2 and Kv11.1 in the rat piriform cortex.
    Hjaeresen ML; Hageman I; Wortwein G; Plenge P; Jørgensen MB
    Brain Res; 2008 Jun; 1217():179-84. PubMed ID: 18511019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 Channels.
    Mauerhöfer M; Bauer CK
    Biophys J; 2016 Aug; 111(3):504-523. PubMed ID: 27508435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium.
    Pedersen PJ; Thomsen KB; Olander ER; Hauser F; Tejada Mde L; Poulsen KL; Grubb S; Buhl R; Calloe K; Klaerke DA
    PLoS One; 2015; 10(9):e0138320. PubMed ID: 26376488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers.
    Fukushiro-Lopes D; Hegel AD; Russo A; Senyuk V; Liotta M; Beeson GC; Beeson CC; Burdette J; Potkul RK; Gentile S
    Front Pharmacol; 2020; 11():577. PubMed ID: 32457608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic regulation of the rapid component of delayed rectifier K+ current: implications for arrhythmogenesis in LQT2 patients.
    Zankov DP; Yoshida H; Tsuji K; Toyoda F; Ding WG; Matsuura H; Horie M
    Heart Rhythm; 2009 Jul; 6(7):1038-46. PubMed ID: 19419905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hERG K(+) channels: structure, function, and clinical significance.
    Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
    Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status.
    Heide J; Zhang F; Bigos KL; Mann SA; Carr VJ; Shannon Weickert C; Green MJ; Weinberger DR; Vandenberg JI
    Am J Psychiatry; 2016 Jan; 173(1):53-9. PubMed ID: 26481172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of potassium channel-blockers in breast cancer.
    Abdul M; Santo A; Hoosein N
    Anticancer Res; 2003; 23(4):3347-51. PubMed ID: 12926074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.